A detailed history of Frontier Capital Management CO LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 125,963 shares of AMPH stock, worth $5.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
125,963
Previous 127,537 1.23%
Holding current value
$5.04 Million
Previous $7.89 Million 29.88%
% of portfolio
0.05%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $67,445 - $99,870
-1,574 Reduced 1.23%
125,963 $5.53 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $9,387 - $13,278
211 Added 0.17%
127,537 $7.89 Million
Q3 2023

Nov 14, 2023

SELL
$45.51 - $65.0 $845,120 - $1.21 Million
-18,570 Reduced 12.73%
127,326 $5.86 Million
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $1.47 Million - $2.4 Million
-41,164 Reduced 22.01%
145,896 $8.38 Million
Q1 2023

May 15, 2023

SELL
$27.99 - $37.92 $473,338 - $641,265
-16,911 Reduced 8.29%
187,060 $7.01 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $16,813 - $18,824
-602 Reduced 0.29%
203,971 $5.72 Million
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $30,040 - $41,147
-1,090 Reduced 0.53%
204,573 $5.75 Million
Q2 2022

Jul 20, 2022

SELL
$29.79 - $42.29 $1.36 Million - $1.93 Million
-45,609 Reduced 18.15%
205,663 $7.16 Million
Q1 2022

Apr 14, 2022

SELL
$22.96 - $36.45 $21,490 - $34,117
-936 Reduced 0.37%
251,272 $9.02 Million
Q4 2021

Jan 19, 2022

SELL
$18.14 - $23.29 $65,394 - $83,960
-3,605 Reduced 1.41%
252,208 $5.87 Million
Q3 2021

Oct 19, 2021

BUY
$17.83 - $21.49 $1.26 Million - $1.52 Million
70,834 Added 38.29%
255,813 $4.86 Million
Q2 2021

Aug 09, 2021

BUY
$17.11 - $20.92 $3.16 Million - $3.87 Million
184,979 New
184,979 $3.73 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.96B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.